Home›People›Jeffrey Allen
Jeffrey Allen

Jeffrey Allen

Chairman & CEO at Evia Bio.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Sep 28, 2026·Suggest an edit

About Jeffrey Allen

Jeffrey Allen is a chairman & CEO at Evia Bio.

Experience

This experience comes from Jeffrey Allen's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jeffrey Allen in the role, so the role may have started earlier or lasted longer.

Evia Bio, Inc. Current
Chairman and CEO
2024 – Present · Minneapolis, MN
Cell preservation products and services for cell therapy companies.
Pluristyx, Inc. Current
Strategic Advisor
2023 – Present
High Ridge Venture Current
Strategic Consultant
2023 – Present
Executive Springboard, LLC Current
Executive Coach
2023 – Present
Charles River Laboratories
CVP Cell Therapy Solutions
2022 – 2023
Gift of Life Biologics
Board Advisor
2022 – 2023
Essent Biologics
Board Advisor
2021 – 2023
Cellero
President and Chief Executive Officer
2019 – 2021
Innovative Blood Resources
Chief Operating Officer and Chief Financial Officer
2015 – 2018
American Red Cross
Chief Executive Officer - Pacific Northwest and Northern CA Regions Biomedical Services
2014 – 2015
Versiti Blood Center of Wisconsin
EVP, Chief Strategy Officer and Chief Financial Officer
2003 – 2014
Baxter International Inc.
Vice President Finance, Global Renal and Europe Middle East and Africa
1987 – 2003

Key Colleagues at Startups

The people Jeffrey Allen works with at each company, as listed on that company's latest Form D.

Evia Bio, Inc. · Form D, Sep 28, 2026
MC
Allison Hubel
Allison Hubel
Founder and Scientific Advisor, director
SF
Scott Fisher
Director
TW

Sources

  1. SECEvia Bio, Inc. Form D, filed Sep 28, 2026